GNUbiotics Sciences is a nutrition company developing and supplying breakthrough nutritional ingredients to influence the microbiome and positively impact the gut for the food and nutrition industries.
Swiss biotech Gnubiotics, announces global launch of GNU100 the first microbiome specialty …
VISION : Accelerate Metabolic Health by restoring gut equilibrium, naturally
Mission: Develop the next generation of Human Milk Oligosaccharide mimics beneficial in establishing a healthy microbiome via selective modulation.
Goals: Develop & commercialize natural ingredients applied to animal, human and medical nutrition.
Why GNUbiotics ingredients are unique?
- Proven efficacy for selective growth of
- Most diverse HMO mimic product available.
- 100% Natural source, no GMO.
GUT NATURALLY UNDERSTOOD
Based on underlying Gut Naturally Understood principles we harness benefit from complex structures with high diversity found in human and animal milk.
‘Influencing the gastrointestinal microbiome to restore gut equilibrium is increasingly viewed as the most sustainable solution for digestive disorders’
GNUbiotics is developing a family of MAC (Microbiota Accessible Carbohydrates) to reproduce the natural diversity and benefits of unique structures found in mothers’ milk.
MACs are complex carbohydrates that are resistant to digestion by a host’s metabolism, and are made available to selected gut bacteria as an energy source.
First in-class microbiome modulating prebiotic for animal feed to be integrated into new pet food recipes to rebalance pets’ microbiota naturally.
GNU100 is a unique rich source of oligosaccharides, containing up to 30 different structures, including sialylated glycans, that can potentially shape intestinal microbiota for gut protection.
GNU100 has a glycan profile similar to what is observed in cat and dog milk. Sialylated glycans such as those present in GNU100 may inhibit pathogen adhesion to epithelial cell walls.
GNU100 is listed in the EU Feed Materials Register as oligosaccharide-peptide complex.
GNUbiotics’ PIPELINE OF MICROBIOTA ACCESSIBLE CARBOHYDRATES (MAC)
Our oligosaccharides complex ingredients are science based and IP protected.
Potential applications for our technology platform include functional food, medical food and dietary supplement.
|Target/Indications||Discovery||Pre Clinical (PoC)||Efficacy||Market Availability|
|Animal Pipeline of Candidates|
|GNU100||Companion Animal gut health||
|Human Pipeline of Candidates|
|GBX||Healthy microbiota (Infant born by C-section)|
|GMX||Dysbiosis microbiota IBD (Inflammatory bowel disease)|
|TVX (Supplements)||Immune defficient diseases|
Richard T. Laube
Co-founder and Chairman
Co-founder & CEO
Yemi Adesokan, PhD
Co-founder & CSO
Bernardo Horta e Costa
Co-founder & CFO
Felix Previdoli, PhD
Director, Product Manufacturing
Yong Miao, PhD
Analytics & Development Manager
Romain Wyss, PhD, PMP
Sara Vidal, PhD
Research Scientist, Microbiology
SCIENTIFIC ADVISORY BOARD
Philippe Steenhout, MD Ped
Director, Medical Affairs
Prof. Dr. Kelly
Prof. Dr. Justin
Prof. Dr. Dirk
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 808639